Brazil and GSK invest in new vaccine partnership
This article was originally published in Scrip
GlaxoSmithKline and the Brazilian government are to invest €70 million (R$183.7 million) on developing new vaccines for dengue fever, yellow fever and malaria, Brazil's health minister, José Gomes Temporão, said.
You may also be interested in...
Performance-based managed entry agreements need to be made more effective, but this can only happen if countries relax their stance on confidentiality and share information on MEAs amongst themselves, says a working paper from the OECD.
The Netherlands will secure lower medicine prices by referencing Norway instead of Germany to set maximum prices.
Luxembourg’s new regulator will work to attract investment and improve public health as well as tackle the growing problem of drug shortages.